|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
| Finance expense on derivative classified instrument | ||
| Gain on marketable securities (net), dividends and interest, held in Trust Account | ||
| Dividends and interest, held in Trust Account | ||
| Change in fair value of derivative liabilities | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other non-current assets | ||
| Accounts payable and accrued expenses (including franchise and income tax payable) | ||
| Net cash provided by (used in) operating activities | ||
| Cash Flows from Investing Activities | ||
| Investment of marketable securities held in Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities | ||
| Proceeds from issuance of Class B and Class K common stock to Sponsor | ||
| Advances from related party | ||
| Proceeds from sale of Class A common stock, net of transaction costs | ||
| Proceeds from sale of Private Placement Shares | ||
| Net cash provided by financing activities | ||
| Net increase in cash | ||
| Net increase (decrease) in cash | ||
| Cash - beginning of period | ||
| Cash - end of period | ||
| Supplemental disclosure of cash flow information: | ||
| Cash paid for income taxes, net of refunds | ||
| Supplemental disclosure of noncash investing and financing activities: | ||
| Underwriting fees payable | ||
| Accretion of Class A common stock to redemption value | ||
| Deferred underwriting fees payable | ||
| Waiver of deferred underwriting fees payable |
Loading...
